Who Owns Regencell Bioscience Stock?
NASDAQ: RGCHealth Care Medicinal Chemicals and Botanical Products USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 0.20%
- Held by insiders
- 88.55%
- Institutional holders
- 35
- Institutions 0.2%
- Insiders 88.5%
- Public and other 11.3%
Who owns Regencell Bioscience stock?
Institutional investors own about 0.2% of Regencell Bioscience's shares, spread across 35 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 88.55% of RGC.
The largest institutional holders are Geode Capital Management, LLC (0.09%), Cerity Partners LLC (0.03%) and Legal & General Group PLC (0.02%). Together, the top 10 institutions control 0.2% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their RGC positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RGC
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 423.37K | 0.09% | +0.3% |
| Cerity Partners LLC | 128.71K | 0.03% | +100.0% |
| Legal & General Group PLC | 108.83K | 0.02% | -15.0% |
| Jane Street Group, LLC | 81.70K | 0.02% | -16.9% |
| Xtx Topco Ltd | 49.06K | 0.01% | -18.3% |
| Susquehanna International Group, LLP | 43.08K | 0.01% | +86.2% |
| Morgan Stanley | 40.59K | 0.01% | +703.4% |
| GSA Capital Partners LLP | 38.92K | 0.01% | +100.0% |
| Savant Capital LLC | 18.25K | 0.00% | +100.0% |
| Polar Asset Management Partners Inc. | 17.02K | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RGC
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 301.86K | 0.06% |
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | 121.51K | 0.02% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 7.60K | 0.00% |
| SPDR INDEX SHARES FUNDS-State Street SPDR S&P China ETF | 4.05K | 0.00% |
| Invesco Exch-Trd Fd. TRT II-Invesco S&P Emerging Markets Momentum ETF | 478 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Regencell Bioscience?
Geode Capital Management, LLC is the largest institutional shareholder of RGC, owning 0.09% of shares outstanding (423.37K shares) as of its latest 13F filing.
What percentage of Regencell Bioscience is owned by institutions?
Institutions own about 0.2% of RGC shares and 1.7% of the public float.
How much of Regencell Bioscience do insiders own?
Insiders, such as officers and directors, own about 88.55% of RGC shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.